North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity
North America biodefense market is expected to grow by 5.3% annually in the forecast period and reach $10.07 billion by 2030 amid the COVID-19 pandemic.
Highlighted with 25 tables and 37 figures, this 103-page report “North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Vaccines
Masks
Other Products
Based on Sales Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America biodefense market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 25 tables and 37 figures, this 103-page report “North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Vaccines
- Anthrax
- Smallpox
- Botulism
- Nuclear/Radiation
- E-Bola
- Zika
- Other Vaccines
- Detectors/Triggering Devices
- Assays and Reagents
- Samplers
- Identifiers
Masks
Other Products
Based on Sales Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Online Sales
- Offline Sales
- Military
- Civilian
- U.S.
- Canada
- Mexico
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America biodefense market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Vaccines
3.2.1 Anthrax
3.2.2 Smallpox
3.2.3 Botulism
3.2.4 Nuclear/Radiation
3.2.5 E-Bola
3.2.6 Zika
3.2.7 Other Vaccines
3.3 Biothreat Detection Devices
3.4 Antibiotics
3.5 Masks
3.6 Other Products
4 SEGMENTATION OF NORTH AMERICA MARKET BY SALES CHANNEL
4.1 Market Overview by Sales Channel
4.2 Online Sales
4.3 Offline Sales
5 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION
5.1 Market Overview by Application
5.2 Military
5.3 Civilian
6 NORTH AMERICA MARKET 2019-2030 BY COUNTRY
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico
7 COMPETITIVE LANDSCAPE
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
8 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT
8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Vaccines
3.2.1 Anthrax
3.2.2 Smallpox
3.2.3 Botulism
3.2.4 Nuclear/Radiation
3.2.5 E-Bola
3.2.6 Zika
3.2.7 Other Vaccines
3.3 Biothreat Detection Devices
3.4 Antibiotics
3.5 Masks
3.6 Other Products
4 SEGMENTATION OF NORTH AMERICA MARKET BY SALES CHANNEL
4.1 Market Overview by Sales Channel
4.2 Online Sales
4.3 Offline Sales
5 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION
5.1 Market Overview by Application
5.2 Military
5.3 Civilian
6 NORTH AMERICA MARKET 2019-2030 BY COUNTRY
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico
7 COMPETITIVE LANDSCAPE
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
8 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT
8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products
LIST OF TABLES
Table 1. Snapshot of North America Biodefense Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in North America Biodefense Market
Table 3. North America Biodefense Market by Product, 2019-2030, $ mn
Table 4. North America Biodefense Market: Vaccines by Application, 2019-2030, $ mn
Table 5. List of Biodefense Vaccine Pipelines
Table 6. North America Biodefense Market: Vaccines Biothreat Detection Devices by Type, 2019-2030, $ mn
Table 7. North America Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 8. North America Market by Application, 2019-2030, $ mn
Table 9. North America Biodefense Market by Country, 2019-2030, $ mn
Table 10. U.S. Biodefense Market by Product, 2019-2030, $ mn
Table 11. U.S. Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 12. U.S. Biodefense Market by Application, 2019-2030, $ mn
Table 13. Canada Biodefense Market by Product, 2019-2030, $ mn
Table 14. Canada Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 15. Canada Biodefense Market by Application, 2019-2030, $ mn
Table 16. Mexico Biodefense Market by Product, 2019-2030, $ mn
Table 17. Mexico Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 18. Mexico Biodefense Market by Application, 2019-2030, $ mn
Table 19. Achaogen, Inc.: Company Snapshot
Table 20. Achaogen, Inc.: Business Segmentation
Table 21. Achaogen, Inc.: Product Portfolio
Table 22. Achaogen, Inc.: Revenue, 2016-2018, $ mn
Table 23. Achaogen, Inc.: Recent Developments
Table 24. Risk Evaluation for Investing in North America Market, 2019-2030
Table 25. Critical Success Factors and Key Takeaways
Table 1. Snapshot of North America Biodefense Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in North America Biodefense Market
Table 3. North America Biodefense Market by Product, 2019-2030, $ mn
Table 4. North America Biodefense Market: Vaccines by Application, 2019-2030, $ mn
Table 5. List of Biodefense Vaccine Pipelines
Table 6. North America Biodefense Market: Vaccines Biothreat Detection Devices by Type, 2019-2030, $ mn
Table 7. North America Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 8. North America Market by Application, 2019-2030, $ mn
Table 9. North America Biodefense Market by Country, 2019-2030, $ mn
Table 10. U.S. Biodefense Market by Product, 2019-2030, $ mn
Table 11. U.S. Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 12. U.S. Biodefense Market by Application, 2019-2030, $ mn
Table 13. Canada Biodefense Market by Product, 2019-2030, $ mn
Table 14. Canada Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 15. Canada Biodefense Market by Application, 2019-2030, $ mn
Table 16. Mexico Biodefense Market by Product, 2019-2030, $ mn
Table 17. Mexico Biodefense Market by Sales Channel, 2019-2030, $ mn
Table 18. Mexico Biodefense Market by Application, 2019-2030, $ mn
Table 19. Achaogen, Inc.: Company Snapshot
Table 20. Achaogen, Inc.: Business Segmentation
Table 21. Achaogen, Inc.: Product Portfolio
Table 22. Achaogen, Inc.: Revenue, 2016-2018, $ mn
Table 23. Achaogen, Inc.: Recent Developments
Table 24. Risk Evaluation for Investing in North America Market, 2019-2030
Table 25. Critical Success Factors and Key Takeaways
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. North America Biodefense Market, 2019-2030, $ mn
Figure 6. Primary Drivers and Impact Factors of North America Biodefense Market
Figure 7. Primary Restraints and Impact Factors of North America Biodefense Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of North America Biodefense Market
Figure 10. Breakdown of North America Biodefense Market by Product, 2019-2030, % of Sales Revenue
Figure 11. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 12. North America Biodefense Market: Vaccines, 2019-2030, $ mn
Figure 13. North America Biodefense Market: Anthrax, 2019-2030, $ mn
Figure 14. North America Biodefense Market: Smallpox, 2019-2030, $ mn
Figure 15. North America Biodefense Market: Botulism, 2019-2030, $ mn
Figure 16. North America Biodefense Market: Nuclear/Radiation, 2019-2030, $ mn
Figure 17. North America Biodefense Market: E-Bola, 2019-2030, $ mn
Figure 18. North America Biodefense Market: Zika, 2019-2030, $ mn
Figure 19. North America Biodefense Market: Other Vaccines, 2019-2030, $ mn
Figure 20. North America Biodefense Market: Biothreat Detection Devices, 2019-2030, $ mn
Figure 21. North America Biodefense Market: Antibiotics, 2019-2030, $ mn
Figure 22. North America Biodefense Market: Masks, 2019-2030, $ mn
Figure 23. North America Biodefense Market: Other Products, 2019-2030, $ mn
Figure 24. Breakdown of North America Biodefense Market by Sales Channel, 2019-2030, % of Sales Revenue
Figure 25. North America Addressable Market Cap in 2020-2030 by Sales Channel, Value ($ mn) and Share (%)
Figure 26. North America Biodefense Market: Online Sales, 2019-2030, $ mn
Figure 27. North America Biodefense Market: Offline Sales, 2019-2030, $ mn
Figure 28. Breakdown of North America Market by Application, 2019-2030, % of Revenue
Figure 29. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 30. North America Biodefense Market: Military, 2019-2030, $ mn
Figure 31. North America Biodefense Market: Civilian, 2019-2030, $ mn
Figure 32. Breakdown of North America Biodefense Market by Country, 2019 and 2030, % of Revenue
Figure 33. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 34. U.S. Biodefense Market, 2019-2030, $ mn
Figure 35. Canada Biodefense Market, 2019-2030, $ mn
Figure 36. Biodefense Market in Mexico, 2015-2026, $ mn
Figure 37. Growth Stage of North America Biodefense Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. North America Biodefense Market, 2019-2030, $ mn
Figure 6. Primary Drivers and Impact Factors of North America Biodefense Market
Figure 7. Primary Restraints and Impact Factors of North America Biodefense Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of North America Biodefense Market
Figure 10. Breakdown of North America Biodefense Market by Product, 2019-2030, % of Sales Revenue
Figure 11. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 12. North America Biodefense Market: Vaccines, 2019-2030, $ mn
Figure 13. North America Biodefense Market: Anthrax, 2019-2030, $ mn
Figure 14. North America Biodefense Market: Smallpox, 2019-2030, $ mn
Figure 15. North America Biodefense Market: Botulism, 2019-2030, $ mn
Figure 16. North America Biodefense Market: Nuclear/Radiation, 2019-2030, $ mn
Figure 17. North America Biodefense Market: E-Bola, 2019-2030, $ mn
Figure 18. North America Biodefense Market: Zika, 2019-2030, $ mn
Figure 19. North America Biodefense Market: Other Vaccines, 2019-2030, $ mn
Figure 20. North America Biodefense Market: Biothreat Detection Devices, 2019-2030, $ mn
Figure 21. North America Biodefense Market: Antibiotics, 2019-2030, $ mn
Figure 22. North America Biodefense Market: Masks, 2019-2030, $ mn
Figure 23. North America Biodefense Market: Other Products, 2019-2030, $ mn
Figure 24. Breakdown of North America Biodefense Market by Sales Channel, 2019-2030, % of Sales Revenue
Figure 25. North America Addressable Market Cap in 2020-2030 by Sales Channel, Value ($ mn) and Share (%)
Figure 26. North America Biodefense Market: Online Sales, 2019-2030, $ mn
Figure 27. North America Biodefense Market: Offline Sales, 2019-2030, $ mn
Figure 28. Breakdown of North America Market by Application, 2019-2030, % of Revenue
Figure 29. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 30. North America Biodefense Market: Military, 2019-2030, $ mn
Figure 31. North America Biodefense Market: Civilian, 2019-2030, $ mn
Figure 32. Breakdown of North America Biodefense Market by Country, 2019 and 2030, % of Revenue
Figure 33. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 34. U.S. Biodefense Market, 2019-2030, $ mn
Figure 35. Canada Biodefense Market, 2019-2030, $ mn
Figure 36. Biodefense Market in Mexico, 2015-2026, $ mn
Figure 37. Growth Stage of North America Biodefense Industry over the Forecast Period
